Influence of nonalcoholic fatty liver disease on response to antiviral treatment in patients with chronic hepatitis B: A meta-analysis

doi:10.4254/wjh.v16.i3.465

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1081)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

HTML

511

Figures (1-5)

Tables (1-1)

Sum=715

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

243

Sum=313

Mar 27, 2024 (publication date) through Jul 26, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Hepatol. Mar 27, 2024; 16(3): 465-476
Published online Mar 27, 2024. doi: 10.4254/wjh.v16.i3.465

Full Size Figure Download Figure

Figure 4 Meta-analysis of the serological responses in only chronic hepatitis B patients and in chronic hepatitis B with nonalcoholic fatty liver disease patients. A: Serological response in only chronic hepatitis B (CHB) patients and in CHB with nonalcoholic fatty liver disease (NAFLD) patients until 48 wk; B: Serological response in only CHB patients and in CHB with NAFLD patients until 96 wk.

Citation: Liu SY, Wang D, Liu J, Yang LP, Chen GY. Influence of nonalcoholic fatty liver disease on response to antiviral treatment in patients with chronic hepatitis B: A meta-analysis. World J Hepatol 2024; 16(3): 465-476
URL: https://www.wjgnet.com/1948-5182/full/v16/i3/465.htm
DOI: https://dx.doi.org/10.4254/wjh.v16.i3.465